This increase also involved the ERK1/2 MAP kinase and NFκB pathways, which is consistent with previously reported data showing the active role of IL-1β in the pathogenesis of multiple pulmonary diseases, such as pulmonary infection, fibrosis, cancer, and emphysema [63], [64]. This evidence concerns the gene MAPK3 and pulmonary emphysema.